Re-evaluation of a biguanide, metformin: mechanism of action and tolerability
References (139)
On the mechanism of action of hypoglycemia-producing biguanides. A reevaluation and a molecular theory
Biochem Pharmacol
(1976)- et al.
Effect of metformin treatment on insulin action in diabetic rats. in vivo and in vitro correlations
Metabolism
(1990) - et al.
Facilitative glucose transporters: an expanding family
Trends Biochem Sci
(1990) - et al.
Treatment of hypertriglyceridemia with metformin: effectiveness and analysis of results
Atherosclerosis
(1977) - et al.
Treatment with low dose metformin in patients with peripheral vascular disease
Pharmacol Res
(1992) - et al.
Genotyping of poor metabolizers of debrisoquin by allele-specific PCR-amplification
Lancet
(1990) - et al.
Determination of metformin and phenformin in human plasma and urine by reversed-phase high performance liquid chromatography
J Chromatogr
(1986) The pharmacology of dichloroacetate
Metabolism
(1989)- et al.
Approche physiopathologique des hyperlactatémies pathologiques chez le diab6tique. Intéret de la metforminémie
Ann Fr Anesth Reanim
(1987) Non-insulin-dependent (type II) diabetes mellitus
Can Med Associ J
(1991)
In't Veld P, Gepts W, Pipeleers DG. Interaction of sulfonylureas with pancreatic β-cells A study with glyburide
Diabetes
(1988)
Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide
Diabetes
(1980)
Secondary failure to treatment with oral antidiabetic agents in non-insulin dependent diabetes
Diabetes Care
(1986)
Effects of glyburide on in vivo insulin-mediated glucose disposal
Am J Med
(1990)
Role of insulin resistance in human disease
Diabetes
(1988)
Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia
Am J Med
(1991)
Insulin resistance and hypertension
Hypertension
(1991)
Metformin revisited: its actions and indications for use
Diabetic Med
(1988)
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type 11 diabetes
Diabetes Care
(1987)
Combined continuous subcutaneous insulin infusion in 10 overweight insulin requiring diabetic patients
Diabete Metab
(1987)
Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas
Diabetologia
(1982)
Effects of exercise training and dietary manipulation on insulin-regulatable glucose-transporter mRNA in rat muscle
Diabetes
(1991)
Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM
Diabetes
(1992)
Stimulation of hexose transport by metformin in L6 muscle cells in culture
Endocrinology
(1992)
Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin
J Clin Invest
(1992)
Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells
Endocrinology
(1992)
Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes
Diabetes
(1993)
Combined metformin-sulphylurea treatment of patients with non insulindependent diabetes in fair to poor glycemic control
J Clin Endocrinol Metab
(1992)
Treating insulin resistance in hypertension with metformin reduces blood pressure and metabolic risk factors
J Int Med
(1991)
Effects of metformin on arterial vasomotion in normal and diabetic Syrian hamsters
Diabete Metab
(1988)
Metformin improves peripheral vascular flow in non hyperlipidemic patients with arterial disease
J Cardiovasc Pharmacol
(1984)
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and the acute phase response
Arteriosclerosis
(1989)
Metformin decreases the elevated levels of plasminogen activator inhibitor, plasma insulin and triglyceride in non diabetic obese subjects
Thromb Haemost
(1987)
The phenformin ban: is the drug an imminent hazard?
Science
(1979)
Guanidines and biguanides
Pharmacol Ther
(1979)
Defective hdyroxylation of phenformin as a determinant of drug toxicity
Diabetes
(1981)
Über die Resorption and den biologischen Abbau von 1-(β-phenäthyl)-biguanid (Phenformin)
Diabetologia
(1967)
Acidose lactique et thérapeutique par biguanides
Journ Annu Diabetol Hotel-Dieu
(1975)
The genetic control of phenformin 4-hydroxylation
J Med Genet
(1985)
Polymorphic drug oxidation in humans
Identification of the primary gene defect at the cytochrome P450 CYP2D locus
Nature
(1990)
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population
J Med Genet
(1980)
Dissociation of coregulatory control of debrisoquine/phenformin and sparteine oxidation in Ghanaians
Clin Pharmacol Ther
(1985)
Disposition of metformin (N,N-dimethylbiguanide) in man
Clin Pharmacol Ther
(1978)
Pharmacokinetics of phenformin in man
J Clin Pharmacol
(1975)
Genetic polymorphism of phenformin 4hydroxylation
Clin Pharmacol Ther
(1982)
Influence of oxidation polymorphism on phenformin kinetics and dynamics
Clin Pharmacol Ther
(1983)
Dosage spectrophotometrique du N-N-dimethylbiguanide dans le sang et l'urine
Ann Biol Clin (Paris)
(1962)
Butylbiguanide concentration in plasma, liver and intestine after intravenous and oral administration to man
Eur J Clin Pharmacol
(1974)
Pharmacokinetics of metformin after intravenous and oral administration to man
Eur J Clin Pharmacol
(1979)
Cited by (0)
Copyright © 1994 Published by Elsevier Ltd.